drugset / Trial / NCT00607711
Study of Oral Palifosfamide Tris in Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study of maximum tolerated dose and safety of oral palifosfamide tris capsules in advanced, refractory, solid tumors
Timeline
- Start
- 2008-03
- Primary completion
- 2009-11
- Completion
- 2009-11
Outcome
Outcome not reported
Stopped: “IND was withdrawn”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | palifosfamide-tris | Other / unclassified | — | Oral |
Indications
No indication recorded.